Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

CD34+ Cell Enrichment

Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases

Bone Marrow Transplantation volume 31, pages 857–860 (2003)Cite this article

Summary

T-cell depletion is an essential step in reducing the risk of graft-versus-host disease (GVHD) in patients with inherited metabolic storage diseases (IMSD) undergoing hematopoietic stem cell transplantation. This goal can be achieved either by selective removal of T cells or by positive selection of CD34+ cells. Large-scale preparations of purified CD34+ cells from bone marrow products have not been extensively described. We report our results with bone marrow CD34+ cell enrichment using the CliniMACS system in eight children with IMSD. The median recovery of positively selected CD34+ cells was 46.2% with a purity of 97.5%, and a residual T cell content of 0.04 × 106. A median of 5.5 × 106/kg of CD34+ cells was infused. All patients engrafted at a median time of 12 days and none of the patients developed GVHD. This method is technically feasible and can be successfully used to transplant children with IMSD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Krivit W, Peters C, Shapiro E-G . Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartyl-glucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999; 12: 167–176.

    Article  CAS  PubMed  Google Scholar 

  2. Rouah E, Gruber R, Shearer W, Armstrong D et al. Graft-versus-host disease in the central nervous system. Am J Clin Pathol 1989; 89: 543–546.

    Article  Google Scholar 

  3. Peters C, Balthazor M, Shapiro EG et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996; 87: 4894–4902.

    CAS  PubMed  Google Scholar 

  4. Peters C, Shapiro EG, Anderson J et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 1998; 91: 2601–2608.

    CAS  PubMed  Google Scholar 

  5. Ho VT, Soiffer RJ . The history and future of T-cell depletion as graft-versus-host prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood. 2001; 98: 3192–3204.

    Article  CAS  PubMed  Google Scholar 

  6. Beaujean F . Methods of CD34+ cell separation: comparative analysis. Tranfus Sci 1997;18: 251–261.

    Article  CAS  Google Scholar 

  7. Handgretinger R, Lang P, Schumm M et al. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 1998; 21: 987–993.

    Article  CAS  PubMed  Google Scholar 

  8. McNiece I, Briddell R, Stoney G et al. Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother 1997; 6: 5–11.

    Article  CAS  PubMed  Google Scholar 

  9. Schumm M, Lang P, Taylor G et al. Isolation of highly purified autogolous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999; 8: 209–218.

    Article  CAS  PubMed  Google Scholar 

  10. Kresse H, von Figura K, Klein U et al. Enzymic diagnosis of the genetic mucopolysaccharide storage disorders. Methods Enzymol 1982; 83: 559–572.

    Article  CAS  PubMed  Google Scholar 

  11. Hopwood JJ, Muller V . Biochemical discrimination of Hurler and Scheie syndromes. Clin Sci 1979; 57: 265–272.

    Article  CAS  Google Scholar 

  12. Wiederschain G, Raghavan S, Kolodny E . Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-beta-D-galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease. Clin Chim Acta 1992; 205: 87–96.

    Article  CAS  PubMed  Google Scholar 

  13. Ugozzoli L, Yam P, Petz LD et al. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 1991; 77: 1607–1615.

    CAS  PubMed  Google Scholar 

  14. de Wynter E-A, Coutinho L-H, Pei X et al. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells 1995; 13: 524–532.

    Article  CAS  PubMed  Google Scholar 

  15. Handgretinger R, Schumm M, Lang P et al. Transplantation of megadose of purified haploidentical stem cells. Ann N Y Acad Sci 1999; 872: 351–361.

    Article  CAS  PubMed  Google Scholar 

  16. Grewal SS, Krivit W, Defor TE et al. Outcome of second hematopoietic cell transplantation in Hurler syndrome. Bone Marrow Transplant 2002; 29: 491–496.

    Article  CAS  PubMed  Google Scholar 

  17. Grainger J, Wynn R, Carr T, Wraith E et al. Stem cell transplantation for mucopolysaccharidoses type 1, Hurler's disease – Results at 5 years follow-up from a single center [abstract]. Bone Marrow Transplant. 2002; 29 (Suppl. 2): 30.

    Google Scholar 

  18. Wagner JE, Santos GW, Noga SJ et al. Bone marrow graft engineering by counterflow elutriation: results of a phase I–II clinical trial. Blood 1990; 75: 1370–1377.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the nonprofit organizations ‘Comitato ML Verga’, PL Mariani Foundation and the Italian MPS Association for their continuous support and Miss Joanna Upton for her review of the manuscript.

Author information

Authors and Affiliations

  1. Clinica Pediatrica, Università di Milano-Bicocca, Ospedale San Gerardo, Monza, Italy

    G Gaipa, N Venturi, P Corti, S Bonanomi, A Balduzzi, D Longoni, C Uderzo, A Biondi, G Masera & A Rovelli

  2. Servizio Trasfusionale, Unità di Aferesi e Criobiologia, Ospedale San Gerardo, Monza, Italy

    M Dassi & P Perseghin

  3. Clinica Pediatrica I, Università di Milano, ICP, Milano, Italy

    R Parini

  4. Istituto Nazionale Neurologico ‘C Besta’, Università di Milano, Milano, Italy

    B Bertagnolio & G Uziel

  5. Division of Hematology/Oncology, Blood and Bone Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA

    C Peters

Authors
  1. G Gaipa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Dassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Perseghin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Venturi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Corti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Bonanomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Balduzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D Longoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Uderzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Biondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. G Masera
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R Parini
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. B Bertagnolio
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. G Uziel
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. C Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. A Rovelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaipa, G., Dassi, M., Perseghin, P. et al. Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases. Bone Marrow Transplant 31, 857–860 (2003). https://doi.org/10.1038/sj.bmt.1704024

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704024

Keywords

This article is cited by

Search

Advanced search

Quick links